Cloverleaf Ecom Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.28 Cr
as on 16-11-2024
- Revenue 52.47%
(FY 2023)
- Profit 20.14%
(FY 2023)
- Ebitda 42.77%
(FY 2023)
- Net Worth 9.00%
(FY 2023)
- Total Assets -29.44%
(FY 2023)
About Cloverleaf Ecom
The Corporate was formerly known as Crossbo Exim Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.28 Cr.
Omkar Abhyankar and Abhishek Jawahirani serve as directors at the Company.
- CIN/LLPIN
U93090MH2015PTC266953
- Company No.
266953
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jul 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Cloverleaf Ecom Private Limited offer?
Cloverleaf Ecom Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, HIV Drugs, Common Disease Medicines, Steroid, Anti Acne Drug, Sexual Wellness Products, Fertility Enhancer, Antiviral Drugs, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs.
Who are the key members and board of directors at Cloverleaf Ecom?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Omkar Abhyankar  | Managing Director | 29-Jul-2015 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhishek Jawahirani | Director | 29-Jul-2015 | Current |
Financial Performance of Cloverleaf Ecom.
Cloverleaf Ecom Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.47% increase. The company also saw a substantial improvement in profitability, with a 20.14% increase in profit. The company's net worth moved up by a moderate rise of 9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cloverleaf Ecom?
In 2022, Cloverleaf Ecom had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Osr Healthcare Private LimitedActive 12 years 9 monthsOmkar Abhyankar and Abhishek Jawahirani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Sep 2018 | ₹1.28 Cr | Open |
How Many Employees Work at Cloverleaf Ecom?
Unlock and access historical data on people associated with Cloverleaf Ecom, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cloverleaf Ecom, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cloverleaf Ecom's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
